Clinical Studies of Safety and Effectiveness of Orphan Products Research Project Grant
Published Date
Agency
CFDA
93.103
Contact Information
Katherine Needleman, 301-796-8660; katherine.needleman@fda.hhs.gov
Deadline
Department
Eligiblity
Nonprofits, for-profits, states, local governments
Guide Page Reference
None
More Information
Program Area
Programe Purpose
To support the clinical development of products for use in rare diseases or conditions where no current therapy exists or where the proposed product will be superior to the existing therapy
